Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells

bone marrow-derived mesenchymal stem cells · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells, covering 2018-07-16 to 2018-07-16. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer [Phase 1]

See pricing